glp 1 glp 2 dual agonist Schematic illustration of monoagonists, agonists and triple Dual GLP-1/GIP Agonist | Tirzepatide
Description
Probl Cardiol

77 Current treatment protocols propose considering weight impact when choosing diabetes treatment strategies, and GLP-1RAs have shown a notably positive therapeutic profile for overweight or obese individuals with T2DM

Canada Mexico Europe Germany France U.K

The animal experiment was approved by the Animal Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (HUST) and its IACUC number is S2095
The difference between 8mg and 12mg is minimal
Concerns have been expressed regarding the effects of these drugs on pancreatic and thyroid tissue, since animal studies and analyses of drug databases indicate an association of GLP-1 receptor agonists with pancreatitis, pancreatic cancer, and thyroid cancer
